Tilray Brands, Inc. (TLRY) Operating Margin
- Operating margin · 12 months: Value -6.88%; Formula and calculation Operating income / revenue. Period ending 2026-05-31..
Operating margin
Overview →Financial period ending 2026-05-31; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Operating margin · 12 months | -6.88% | Operating income / revenue. Period ending 2026-05-31. $-63.03M ÷ $915.45M × 100 ≈ -6.88% |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Operating income | -63.03M USD | Operating Income (Loss) |
| Revenue | 915.45M USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Cost of products and services | 655.01M USD | Cost of Goods and Services Sold |
| Research and development | 361.00K USD | Research and Development Expense |
| Selling, general and administration | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Operating income (USD) | Revenue (USD) | Cost of products and services (USD) | Research and development (USD) | Selling, general and administration (USD) | Operating margin |
|---|---|---|---|---|---|---|
| 2026-05-31 | $-63.03M | $915.45M | $655.01M | $361.00K | (m) | -6.88% |
| 2026-02-28 | $-1.49B | $858.27M | $620.72M | $215.00K | (m) | -173.67% |
| 2025-11-30 | $-2.22B | $837.32M | $602.71M | $238.00K | (m) | -265.62% |
| 2025-08-31 | $-2.24B | $830.77M | $592.43M | $220.00K | (m) | -270.12% |
| 2025-05-31 | $-2.28B | $821.31M | $580.74M | $284.00K | (m) | -277.93% |
| 2025-02-28 | $-855.25M | $826.66M | $571.37M | $644.00K | (m) | -103.46% |
| 2024-11-30 | $-177.41M | $829.22M | $576.54M | $665.00K | (m) | -21.40% |
| 2024-08-31 | $-176.95M | $812.04M | $573.18M | $661.00K | (m) | -21.79% |
| 2024-05-31 | $-174.75M | $788.94M | $565.59M | $635.00K | (m) | -22.15% |
| 2024-02-29 | $-248.20M | $743.25M | $535.08M | $421.00K | (m) | -33.39% |
| 2023-11-30 | $-1.37B | $700.50M | $553.43M | $486.00K | (m) | -195.98% |
| 2023-08-31 | $-1.38B | $650.86M | $508.32M | $595.00K | (m) | -212.47% |
| 2023-05-31 | $-1.37B | $627.12M | $480.16M | $682.00K | (m) | -218.41% |
| 2023-02-28 | $-1.75B | $596.26M | $523.20M | $556.00K | (m) | -293.01% |
| 2022-11-30 | $-558.47M | $602.54M | $480.71M | $549.00K | (m) | -92.69% |
| 2022-08-31 | $-562.21M | $613.56M | $499.08M | $899.00K | (m) | -91.63% |
| 2022-05-31 | $-610.40M | $628.37M | $511.56M | $1.52M | (m) | -97.14% |
| 2022-02-28 | $-216.66M | $617.28M | $471.24M | $1.82M | (m) | -35.10% |
| 2021-11-30 | $-220.95M | $589.31M | $452.64M | $1.78M | (m) | -37.49% |
| 2021-08-31 | $-192.23M | $563.62M | $424.43M | $1.50M | (m) | -34.11% |
| 2021-05-31 | $-132.17M | $513.09M | $389.90M | $830.00K | (m) | -25.76% |
| 2021-03-31 | $-203.18M | (m) | $179.11M | $4.27M | (m) | (m) |
| 2021-02-28 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-12-31 | $-201.12M | (m) | $185.83M | $4.41M | (m) | (m) |
| 2020-11-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-09-30 | $-396.35M | (m) | (m) | $4.50M | (m) | (m) |
| 2020-08-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-06-30 | $-387.37M | (m) | (m) | $5.89M | (m) | (m) |
| 2020-05-31 | $-104.01M | $405.33M | $309.27M | $1.92M | (m) | -25.66% |
| 2020-03-31 | $-344.51M | (m) | (m) | $6.77M | (m) | (m) |
| 2019-12-31 | $-301.70M | (m) | (m) | $6.56M | (m) | (m) |
| 2019-09-30 | $-106.57M | (m) | (m) | $6.74M | (m) | (m) |
| 2019-06-30 | $-103.31M | (m) | (m) | $5.23M | (m) | (m) |
| 2019-05-31 | $-138.93M | $179.30M | $135.79M | $1.05M | (m) | -77.48% |
| 2019-03-31 | $-81.78M | (m) | (m) | $4.34M | (m) | (m) |
| 2018-12-31 | $-57.65M | (m) | (m) | $4.26M | (m) | (m) |
| 2018-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2018-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2018-03-31 | $-10.85M | (m) | (m) | (m) | (m) | (m) |
| 2017-12-31 | $-7.50M | (m) | (m) | $3.17M | (m) | (m) |
| 2017-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-03-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2016-12-31 | $-7.05M | (m) | (m) | $1.14M | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Canopy Growth Corp (CGC) | $0.395B | ||
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |